• Blueprint Medicines' (BPMC) Overweight Rating Reaffirmed at Stephens

    Источник: Buzz FX / 02 янв 2025 09:51:14   America/New_York


    Blueprint Medicines' (BPMC) Overweight Rating Reaffirmed at Stephens Written by MarketBeat January 2, 2025 Share Link copied to clipboard. Blueprint Medicines ( NASDAQ:BPMC - Get Free Report ) 's stock had its "overweight" rating restated b
    Read more...
Опубликовать